跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PEMETREXED POWDER FOR SOLUTION FOR INFUSION 500mg/vial - HSA Drug Approval Details
Approvals
/
HSA
/
PEMETREXED POWDER FOR SOLUTION FOR INFUSION 500mg/vial
Approved
THERAPEUTIC
PEMETREXED POWDER FOR SOLUTION FOR INFUSION 500mg/vial
Mylan Laboratories Limited [OTL]
🇸🇬 Health Sciences Authority
Approval Date
Apr 10, 2014
Approval ID
99df21f3b1d628e4
Company
Mylan Laboratories Limited [OTL]
Type
Therapeutic
Approval Details
Approval Id
99df21f3b1d628e4
Drug Name
PEMETREXED POWDER FOR SOLUTION FOR INFUSION 500mg/vial
Product Name
PEMETREXED POWDER FOR SOLUTION FOR INFUSION 500mg/vial
Approval Number
SIN14536P
Approval Date
2014-04-10
Registrant
MYLAN PHARMACEUTICALS PTE. LTD.
Licence Holder
MYLAN PHARMACEUTICALS PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
L01BA04
Atc Item Name
pemetrexed
Pharma Manufacturer Name
mylan pharmaceuticals pte. ltd.
Active Ingredients
Pemetrexed disodium 551.424mg eqv Pemetrexed
500mg
PEMETREXED DISODIUM 551.424 MG EQV PEMETREXED
500 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 10, 2014
Approval ID
99df21f3b1d628e4
Type
Therapeutic
Back to HSA Approvals
